Use of Bivalirudin During Percutaneous Coronary Intervention in Patients With Diabetes Mellitus
- 25 May 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 45 (12) , 1932-1938
- https://doi.org/10.1016/j.jacc.2005.02.074
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Short- and long-term results after multivessel stenting in diabetic patientsJournal of the American College of Cardiology, 2004
- Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: Lessons from the GUSTO V trialJournal of the American College of Cardiology, 2004
- Predictors of long-term mortality after hospitalization for primary unstable angina pectoris and non–ST-elevation myocardial infarctionThe American Journal of Cardiology, 2003
- Prevalence of risk factors, and not gender per se, determines short- and long-term survival after coronary artery bypass surgeryJournal of Cardiothoracic and Vascular Anesthesia, 2003
- Atherothrombosis, inflammation, and diabetesJournal of the American College of Cardiology, 2003
- Bivalirudin and Provisional Glycoprotein IIb/IIIa Blockade Compared With Heparin and Planned Glycoprotein IIb/IIIa Blockade During Percutaneous Coronary InterventionJAMA, 2003
- Platelet Glycoprotein IIb/IIIa Inhibitors Reduce Mortality in Diabetic Patients With Non–ST-Segment-Elevation Acute Coronary SyndromesCirculation, 2001
- Impact of Diabetes on Long-Term Prognosis in Patients With Unstable Angina and Non–Q-Wave Myocardial InfarctionCirculation, 2000
- Abciximab reduces mortality in diabetics following percutaneous coronary interventionJournal of the American College of Cardiology, 2000
- Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty.Circulation, 1997